Learn, Analyse & Invest
only with
only with
+91
Download Orca
Belding India Ltd.
Belding India
₹ 0.00
0.00 (0.00)%
NSE
BSE
Manufacturing
Small-cap - With a market cap of ₹22.58 Cr.
| EX-Date | Purpose |
|---|---|
| 23 06 2021 | Audited Results |
| 14 08 2021 | Quarterly Results & A.G.M. |
| 02 11 2021 | Quarterly Results |
| 08 02 2022 | Quarterly Results |
| 30 05 2022 | Quarterly Results & Audited Results |
| 08 08 2022 | Quarterly Results & A.G.M. |
| 14 11 2022 | Quarterly Results |
| 31 01 2023 | Quarterly Results |
| 30 05 2023 | Audited Results |
| 14 08 2023 | Quarterly Results |
| 10 11 2023 | Quarterly Results |
| 13 02 2024 | Quarterly Results |
| 14 11 2024 | Quarterly Results |
| 14 02 2025 | Quarterly Results & Inter alia, to consider and approve:- 1) To consider and approve Business Transfer Arrangement (?BTA?) for transfer of the Company?s business under slump sale. |
| 29 05 2025 | Audited Results |
| 08 08 2025 | Quarterly Results |
| 04 09 2025 | Consolidation of Shares |
| 06 11 2025 | Preferential Issue of shares & Inter alia, to consider and approve:- a) to consider and evaluate a proposal issuance of equity shares or any eligible securities or a combination thereof through a preferential issue on a private placement basis, qualified institutional placement, rights issue or through any other permissible mode as may be considered appropriate, subject to such regulatory/ statutory approvals as may be required including the approval of the members of the Company, and to approve such ancillary actions in relation to the above as may be required |
| 07 11 2025 | Preferential Issue of shares & inter alia, a) to consider and evaluate a proposal issuance of equity shares or any eligible securities or a combination thereof through a preferential issue on a private placement basis, qualified institutional placement, rights issue or through any other permissible mode as may be considered appropriate, subject to such regulatory/ statutory approvals as may be required including the approval of the members of the Company, and to approve such ancillary actions in relation to the above as may be required |
| 14 11 2025 | Quarterly Results |
| 12 02 2026 | Quarterly Results |
News
